Polaryx Therapeutics, Inc. (PLYX) Stock Price & Analysis

Polaryx Therapeutics, Inc. (PLYX) rose 3.20% to USD 2.09 as of September 9, 2026 at 14:41 UTC, according to Nexqual real-time market data.

PLYX last closed at USD 2.09; the session ranged USD 2.02–2.12 on volume of 13,497 shares. Market capitalization is —, with a 52-week range of USD 1.85–48.91 (NCM). Source: Nexqual, September 9, 2026 at 14:41 UTC.

Key Statistics (as of September 9, 2026 at 14:41 UTC)

PriceUSD 2.09
Change▲ 3.20% (up)
Previous CloseUSD 2.09
OpenUSD 2.09
Day RangeUSD 2.02 – 2.12
52-Week RangeUSD 1.85 – 48.91
Volume13,497 shares
Market Cap
ExchangeNCM

Technical Analysis (PLYX)

Nexqual's technical model rates PLYX "SELL" based on 1 bullish and 4 bearish signals across 128 daily candles, as of September 9, 2026 at 14:41 UTC.

Overall SignalSELL
RSI (14)50.3 (neutral)
vs SMA50Below (USD 2.22)
MACD-0.06 (negative)

From Polaryx Therapeutics, Inc.'s Latest SEC 10-K Filing (filed 2026-03-24)

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
OBAIOur Bond, Inc.USD 0.34▲ 1.21%
TMDETMD Energy LimitedUSD 0.8▲ 11.85%
SERSerina Therapeutics, Inc.USD 2.55▼ 6.59%
MRNOMurano Global Investments PLCUSD 0.21▲ 1.33%
SLGBSmart Logistics Global LimitedUSD 0.42▼ 7.98%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 14:41 UTC. This page is informational and not investment advice.